Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- 1 June 2010
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 17 (6), 574-583
- https://doi.org/10.1016/j.ccr.2010.04.011
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Evolution of clinical trials in head and neck cancerCritical Reviews in Oncology/Hematology, 2009
- The use of copper-lowering therapy with tetrathiomolybdate in medicineExpert Opinion on Investigational Drugs, 2008
- Progress in Gynecologic Cancer Research: The Gynecologic Oncology Group ExperienceSeminars in Oncology, 2008
- Chemotherapy for recurrent and metastatic cervical cancerGynecologic Oncology, 2008
- Natural history and epidemiology of HPV infection and cervical cancerGynecologic Oncology, 2008
- The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using μSRXRF and μXANESPhysics in Medicine & Biology, 2008
- Mechanisms for copper acquisition, distribution and regulationNature Chemical Biology, 2008
- Medical treatment for advanced gastroesophageal adenocarcinomaCurrent Opinion in Gastroenterology, 2007
- Role of platinum agents in the management of advanced pancreatic cancerExpert Opinion on Pharmacotherapy, 2007
- Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper—A ReviewIntegrative Cancer Therapies, 2002